Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example von Dalhoff, A.

Volltext

Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode o... von Dalhoff, A.

Volltext

Immunomodulatory activities of fluoroquinolones von Dalhoff, A

Volltext

Resistance surveillance studies : a multifaceted problem - the fluoroquinolone example von DALHOFF, A

Volltext

Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates f... von Dalhoff, A, Schubert, S, Vente, A

Volltext

Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections von Wagenlehner, F, Nowicki, M, Bentley, C, Lückermann, M, Wohlert, S, Fischer, C, Vente, A, Naber, K, Dalhoff, A

Volltext

In vitro antibacterial activity and pharmacodynamics of new quinolones von DALHOFF, A, SCHMITZ, F.-J

Volltext

Pharmacokinetics, Safety, and Tolerability of Ascending Single Doses of Moxifloxacin, a New 8-Methoxy Quinolone, Administered to Healthy Subjects von STASS, H, DALHOFF, A, KUBITZA, D, SCHUHLY, U

Volltext

Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle von Dalhoff, A., Rashid, M.-U., Kapsner, T., Panagiotidis, G., Weintraub, A., Nord, C.E.

Volltext

Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints von Dalhoff, A, Ambrose, P. G, Mouton, J. W

Volltext

Pharmacodynamics of fluoroquinolones von Dalhoff, A

Volltext

Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern von Dalhoff, Axel A.H, Levy, Stuart B

Volltext

Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model von Dalhoff, A

Volltext

Comparative In Vitro and In Vivo Activity of the C-8 Methoxy Quinolone Moxifloxacin and the C-8 Chlorine Quinolone BAY y 3118 von Dalhoff, A

Volltext

Activity of quinolones against gram-positive cocci: Mechanisms of drug action and bacterial resistance von SCHMITZ, F.-J, HIGGINS, P. G, MAYER, S, FLUIT, A. C, DALHOFF, A

Volltext

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial von Cornely, Oliver A, Prof, Crook, Derrick W, Prof, Esposito, Roberto, Prof, Poirier, André, MD, Somero, Michael S, MD, Weiss, Karl, Prof, Sears, Pamela, PhD, Gorbach, Sherwood, Prof

Volltext

Immunomodulatory effects of quinolones von Dalhoff, Axel, Shalit, Itamar

Volltext

Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide von Dalhoff, A, Schubert, S, Ullmann, U

Volltext

A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss von Schilder, Anne G. M., Wolpert, Stephan, Saeed, Shakeel, Middelink, Leonie M., Edge, Albert S. B., Blackshaw, Helen, Pastiadis, Kostas, Bibas, Athanasios G.

Volltext

The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints von Stass, H, Dalhoff, A

Volltext